Press Releases Lavipharm S.A.

Equities

Delayed Athens S.E. Other stock markets 07:43:43 2024-04-29 am EDT			5-day change	1st Jan Change
0.852 ^EUR	-0.93%		+0.59%	+7.04%

Feb. 28	Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	CI

Lavipharm S A : Annual Analysts Briefing	Apr. 24	PU
Lavipharm S A : ANNOUNCEMENT	Dec. 11	PU
Lavipharm S A : enters into a new asset purchase agreement	Dec. 11	PU
Lavipharm S A : Asset Purchase Agreement for Lavipharm	Dec. 01	PU
Lavipharm S A : FINANCIAL RESULTS FIRST HALF OF 2023	23-09-21	PU
Lavipharm S A : First Half 2023 Financial Results – Strong EBITDA increase	23-09-21	PU
Lavipharm S A : Annual Shareholders’ Meeting	23-07-06	PU
Lavipharm S A : PRESS RELEASE SHAREHOLDERS MEETING	23-07-06	PU
Lavipharm S A : Press Release Extraordinary Shareholders’ Meeting	23-05-26	PU
Lavipharm S A : Results Q1 2023	23-05-04	PU
Lavipharm S A : AMENDMENT OF THE 2023 FINANCIAL CALENDAR	23-04-27	PU
Lavipharm S A : ANNOUNCEMENT	23-03-28	PU
Lavipharm S A : Announcement 1668/2023	23-03-15	PU
Lavipharm S A : further enhances its product portfolio in Urology	23-02-01	PU
Lavipharm S A : share re-enters ATHEX Main Market	22-12-21	PU
Lavipharm S A : Tikun Europe and Lavipharm enter into a strategic alliance	22-11-15	PU
Lavipharm : Annual Shareholders’ Meeting	22-06-29	PU
Lavipharm S A : HEAD OF INVESTORS' RELATIONS	22-01-18	PU
Lavipharm S A : Announcement 9482/2021 (no English translation available)	21-11-30	PU
Lavipharm S A : Announcement 9142/2021 (no English translation available)	21-11-22	PU

No results for this search